MapLight Therapeutics, Inc.

NasdaqGS:MPLT Stock Report

Market Cap: US$1.7b

MapLight Therapeutics Management

Management criteria checks 2/4

MapLight Therapeutics' CEO is Chris Kroeger, appointed in Jan 2018, has a tenure of 8.5 years. total yearly compensation is $25.62M, comprised of 2.6% salary and 97.4% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth $4.32M. The average tenure of the management team and the board of directors is 5.6 years and 3.1 years respectively.

Key information

Chris Kroeger

Chief executive officer

US$25.6m

Total compensation

CEO salary percentage2.56%
CEO tenure8.5yrs
CEO ownership0.3%
Management average tenure5.6yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

Seeking Alpha • Jun 25

MapLight Therapeutics: The Cobenfy Challenger Does Not Look Like A Bargain

Summary MapLight Therapeutics was assigned a Hold rating ahead of its Phase 2 ZEPHYR readout for ML-007C-MA in schizophrenia expected in mid-August. ML-007C-MA is positioned as a best-in-class challenger to Cobenfy, with differentiation in tolerability, dosing convenience, and potentially efficacy. ML-004 recently failed its primary endpoint in the autism indication, while meaningful improvement in a prespecified subgroup provided a path forward. My rNPV-based model estimates a fair value for MPLT that is broadly in line with the current stock price, suggesting a balanced risk-reward profile prior to the upcoming catalyst. Read the full article on Seeking Alpha

CEO Compensation Analysis

How has Chris Kroeger's remuneration changed compared to MapLight Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

-US$199m

Dec 31 2025US$26mUS$655k

-US$161m

Sep 30 2025n/an/a

-US$103m

Jun 30 2025n/an/a

-US$92m

Mar 31 2025n/an/a

-US$81m

Dec 31 2024US$9mUS$628k

-US$78m

Mar 31 2024n/an/a

-US$63m

Dec 31 2023US$5mUS$602k

-US$56m

Compensation vs Market: Chris's total compensation ($USD25.62M) is above average for companies of similar size in the US market ($USD5.16M).

Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.

CEO

Chris Kroeger (58 yo)

8.5yrs
Tenure
US$25,624,254
Compensation

Dr. Christopher A. Kroeger, also known as Chris, M.D., Ph D., MBA is Founder of MapLight Therapeutics, Inc. and has been its President, Chief Executive Officer and Director from 2018. He serves as Director...

Leadership Team

NamePositionTenureCompensationOwnership
Christopher Kroeger
Founder8.5yrsUS$25.62m0.25%
$ 4.3m
Robert Malenka
Co-Founder & Member of Scientific Advisory Boardno dataUS$3.22m0.48%
$ 8.2m
Erin Foff
Chief Medical Officer5.2yrsUS$6.25m0.76%
$ 13.1m
Karoly Nikolich
Founderno datano datano data
Karl Deisseroth
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Jonathan Gillis
Chief Admin & Acc Officer2.3yrsno data0%
$ 0
James Lillie
Chief Scientific Officer7.4yrsno data0.54%
$ 9.2m
Kristopher Hanson
General Counsel & Secretary3.3yrsno data0.36%
$ 6.1m
Anatol Kreitzer
Chief Discovery Officer6.1yrsno data0.47%
$ 8.0m
5.6yrs
Average Tenure
56yo
Average Age

Experienced Management: MPLT's management team is seasoned and experienced (5.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Christopher Kroeger
Founder8.5yrsUS$25.62m0.25%
$ 4.3m
Robert Malenka
Co-Founder & Member of Scientific Advisory Boardno dataUS$3.22m0.48%
$ 8.2m
Karl Deisseroth
Co-Founder & Member of Scientific Advisory Boardno datano datano data
George Pavlov
Independent Chairman of the Board7.4yrsUS$9.66k0.055%
$ 946.7k
Maria Walker
Independent Director2.4yrsUS$895.18k0.017%
$ 283.3k
Timothy Garnett
Independent Director3yrsUS$728.40k0.15%
$ 2.6m
Nanna Luneborg
Independent Director1yrUS$10.58kno data
Suzanne Hendrix
Member of Clinical Advisory Boardno datano datano data
Hongkui Zeng
Member of Scientific Advisory Board3.3yrsno datano data
Ivan Soltesz
Member of Scientific Advisory Boardno datano datano data
Matthew State
Member of Scientific Advisory Boardno datano datano data
Anissa Abi-Dargham
Member of Clinical Advisory Boardno datano datano data
3.1yrs
Average Tenure
62.5yo
Average Age

Experienced Board: MPLT's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/19 05:43
End of Day Share Price 2026/07/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MapLight Therapeutics, Inc. is covered by 13 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sumant Satchidanand KulkarniCanaccord Genuity
Adam VogelCraig-Hallum Capital Group LLC
Raghuram SelvarajuH.C. Wainwright & Co.